This is a promotional website intended for UK healthcare professionals.
Colobreathe® (colistimethate sodium) Prescribing Information can be found here.
Adverse Event Reporting Information can be found at the end of this page.
This is a promotional website intended for UK healthcare professionals.
Colobreathe® (colistimethate sodium) Prescribing Information can be found here.
Adverse Event Reporting Information can be found at the end of this page.
Medical Information contact
Email:
essentialpharmaUK@EU.ProPharmaGroup.com
Telephone:
+44 (0)1423 850700
CF, cystic fibrosis.
References:
1. Schuster A, Haliburn C, Döring G, et al. Thorax 2013;68:344–350.
2. Colobreathe® Summary of Product Characteristics. Available here.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for the MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Essential Pharma on +44 (0) 1423 850700 or at EssentialpharmaUK@EU.ProPharmaGroup.com.
Essential Pharma Ltd, 8A Crabtree Road, Egham, Surrey, TW20 8RN, United Kingdom
Colobreathe® is a registered trademark of Essential Pharma. Copyright © 2026 Essential Pharma
MAT-COL-GB-0005-1224 May 2025
